<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04042454</url>
  </required_header>
  <id_info>
    <org_study_id>EBB18TA19425</org_study_id>
    <nct_id>NCT04042454</nct_id>
  </id_info>
  <brief_title>To Assess the Safety and Tolerance of Infant Formula With Locust Bean Gum in Infants With Regurgitation</brief_title>
  <acronym>Solar</acronym>
  <official_title>A Randomized, Controlled Study to Evaluate the Safety and Tolerance of an Infant Formula With Locust Bean Gum in Infants With Regurgitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nutricia Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nutricia Research</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized, controlled study to evaluate the safety and tolerance of an infant formula with&#xD;
      locust bean gum in infants with regurgitation. (Solar)&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 10, 2019</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average stool consistency</measure>
    <time_frame>8 weeks</time_frame>
    <description>The average stool consistency (based on the 4-point Brussels Infant and Toddler Stool Scale [BITSS]) of the 8th week of intervention, adjusted for the baseline stool consistency score. Catagories are hard stools, formed stools, loose stools and watery stools. https://bitss-stoolscale.com/ (assessed 31-Jan-19) can be used as a further reference.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Regurgitation, Gastric</condition>
  <arm_group>
    <arm_group_label>Test Product</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cow's milk-based infant formula containing the thickener locust bean gum containing prebiotic oligosaccharides and postbiotics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Product</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cow's milk-based infant formula containing prebiotic oligosaccharides and postbiotics</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>milk based anti-regurgitation infant formula</intervention_name>
    <description>Cow's milk-based infant formula containing the thickener locust bean gum containing prebiotic oligosaccharides and postbiotics</description>
    <arm_group_label>Test Product</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Milk based infant formula</intervention_name>
    <description>Cow's milk-based infant formula containing prebiotic oligosaccharides and postbiotics</description>
    <arm_group_label>Control Product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Singleton infants with regurgitation who are otherwise healthy&#xD;
&#xD;
          2. Diagnosed with regurgitation according to the (adapted) Rome IV diagnostic criteria.&#xD;
&#xD;
          3. Term infants with a gestational age at birth of ≥37 weeks + 0 days and ≤41 weeks + 6&#xD;
             days&#xD;
&#xD;
          4. Aged &gt; 3 weeks (21 days) and &lt; 9 weeks (63 days) at screening&#xD;
&#xD;
          5. Exclusively formula fed for ≥ 7 days before screening&#xD;
&#xD;
          6. Written informed consent from the parent(s) and/or legally acceptable&#xD;
             representative(s)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Low birth weight for gestational age and gender&#xD;
&#xD;
          2. Infants diagnosed with or suspected to have gastroesophageal reflux disease (GERD). I&#xD;
&#xD;
          3. Infants who received any of the following medication within 4 weeks prior to&#xD;
             screening: systemic antibiotics, prokinetics and/or proton pump inhibitors and/or&#xD;
             (other) medication to treat regurgitation&#xD;
&#xD;
          4. Infants who already consumed a thickened anti-regurgitation (AR) formula or used&#xD;
             thickening supplements&#xD;
&#xD;
          5. Infants who already started complementary feeding&#xD;
&#xD;
          6. Infants with a gastrointestinal infection within 4 weeks prior to screening&#xD;
&#xD;
          7. Infants with a congenital condition, previous or current illness, and/or medication&#xD;
             use that could interfere with the main study outcomes according to the investigator&#xD;
&#xD;
          8. Infants known or suspected to have: allergy for fish, soy protein, soy oil or corn;&#xD;
             lactose intolerance; galactosaemia including history of any other allergic&#xD;
             manifestations or known allergy to any of the study product ingredients and/or&#xD;
             requiring a fibre-free diet&#xD;
&#xD;
          9. Infants known or suspected to have allergy to cow's milk protein&#xD;
&#xD;
         10. Presence of any other gastrointestinal symptom(s)/disorder(s) that are not functional&#xD;
             in nature, as assessed by the investigator's clinical judgement&#xD;
&#xD;
         11. Participation in any other studies involving investigational or marketed products&#xD;
             concomitantly or prior to screening&#xD;
&#xD;
         12. Incapability of the parent(s) to comply with the study protocol or investigator's&#xD;
             uncertainty about the willingness or ability of the parent(s) to comply with the&#xD;
             protocol requirements&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>9 Weeks</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gerda Gerda van Wijhe</last_name>
    <phone>+31302095000</phone>
    <email>gerda.vanwijhe@danone.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>A.O.U. Ospedali Riuniti di Ancona</name>
      <address>
        <city>Ancona</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>C Catassi, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale pediatrico Giovanni XXIII</name>
      <address>
        <city>Bari</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R Francavilla, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria G. Martino</name>
      <address>
        <city>Messina</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>C Romano, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale dei bambini Buzzi</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>G Lista, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale F. Del Ponte</name>
      <address>
        <city>Varese</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>S Salvatore, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Poliklinika Ginekologiczno-Położnicza Sp. z o.o. Sp. k.</name>
      <address>
        <city>Białystok</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bartosz Kasprzaka</last_name>
    </contact>
    <investigator>
      <last_name>M Arciszewska, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Osrodek badan Klinicznych IN-VIVO sp. z o.o.</name>
      <address>
        <city>Bydgoszcz</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>P Korbal, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gabinet Lekarski</name>
      <address>
        <city>Rzeszów</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>B Korczowski, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>NZLA Michalkowice Jarosz</name>
      <address>
        <city>Siemianowice Śląskie</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>B Pajek, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Alergo-Med Specjalistyczna Przychodnia Lekarska sp. z o.o</name>
      <address>
        <city>Tarnów</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olechowski, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>EPOKA Niepubliczny Zaklad Opieki Zdrowotnej Piotr Chodkiewicz Sp. z o.o</name>
      <address>
        <city>Żnin</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M Durczak-Hillemann, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Communal Nonprofit Enterprise &quot;City Children's Clinical Hospital</name>
      <address>
        <city>Dnipro</city>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M Gonchar, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Communal Nonprofit Enterprise &quot;City Children's Clinical Hospital</name>
      <address>
        <city>Kharkiv</city>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Klymenko, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Communal Nonprofit Enterprise &quot;Lviv City Children's Clinical Hospital&quot;</name>
      <address>
        <city>Lviv</city>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>S Nyankovskyy, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Communal Enterprise &quot;Poltava Regional Children's Clinical Hospital of Poltava Regional Council</name>
      <address>
        <city>Poltava</city>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Pokhylko, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Communal Non-Profit Enterprise of Sumy Regional Council &quot;Regional Children Clinical Hospita</name>
      <address>
        <city>Sumy</city>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loboda, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>Poland</country>
    <country>Ukraine</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 30, 2019</study_first_submitted>
  <study_first_submitted_qc>August 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2019</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Laryngopharyngeal Reflux</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

